Veterinary Molecular Diagnostics Global Market Report 2026
상품코드:1938737
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
수의용 분자진단 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 7억 달러에서 2026년에는 7억 7,000만 달러로, CAGR 9.9%로 확대될 전망입니다. 지난 수년간의 성장 요인으로는 동물 전염병 및 유전성 질환의 증가, 분자생물학 분야의 기술 발전, 반려동물 및 가축 사육두수 증가, 수의학적 인식 및 교육 향상, 기존 분자진단 키트의 도입 등을 꼽을 수 있습니다.
수의용 분자진단 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 11억 1,000만 달러에 달하고, CAGR은 9.6%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 신속하고 정확한 분자진단에 대한 수요 증가, 차세대 염기서열 분석(NGS) 및 하이스루풋 플랫폼 도입 확대, 수의학 유전체학 서비스 확대, AI 기반 진단 분석의 통합, 분자 검사를 통한 예방 수의학에 대한 집중도 강화 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 PCR 및 RT-PCR 기반 진단법 확대, 수의학 분야에서 차세대 염기서열 분석(NGS) 채택 증가, 감염성 질환을 위한 다중 진단 키트 개발, 일상적인 수의학에 분자진단의 통합, 자동화 및 고처리량 분자 검사 솔루션의 보급 등이 있습니다. 보급을 들 수 있습니다.
동물의 인수공통전염병의 높은 유병률이 향후 수의용 분자진단 시장의 성장을 견인할 것으로 예상됩니다. 인수공통전염병은 세균, 바이러스, 기생충, 곰팡이 등에 의해 발생하며 동물과 사람 사이에 전파되는 감염병을 말합니다. 대표적인 예로는 광견병, 라임병, 살모넬라증, 톡소플라스마증 등을 들 수 있습니다. 이러한 질병의 유병률은 삼림 벌채, 야생동물 착취, 집약적 축산, 생물 다양성 손실, 인간의 이동성 등의 요인에 의해 영향을 받습니다. 수의용 분자진단 기술은 동물의 인수공통전염병을 조기에 발견하고, 신속하고 정확한 병원체 동정을 통해 인체 감염 예방 및 질병 관리 향상에 기여합니다. 예를 들어, 2025년 12월 유럽질병예방관리센터(ECDC: European Center for Disease Control and Prevention)의 보고서에 따르면, 2024년 보고된 주요 인수공통전염병의 인체 감염 사례(캄필로박터증: 168,396건, 살모넬라증: 79,703건 등)가 지속적으로 증가하고 있다고 합니다. 79,703건 등)이 지속적으로 증가하여 유럽에서 인수공통전염병이 지속적으로 확산되고 있는 것으로 나타났습니다. 따라서, 인수공통전염병의 높은 유병률이 수의용 분자진단 시장을 주도하고 있습니다.
수의용 분자진단 시장의 주요 기업들은 진단 정확도 향상, 검사 효율화, 동물의 신속한 질병 검출을 위해 고처리량 검사 장비 등 진단 기술의 자동화와 확장성에 초점을 맞추고 있습니다. 고처리능력 검사 장비는 특히 대규모 검사에서 실험실 및 임상현장에서 신속하고 정확한 분석을 지원하며, 다수의 검체를 효율적으로 처리할 수 있는 첨단 진단기기입니다. 예를 들어, 2023년 6월 미국 아이오와주립대 수의진단연구소(VDL)는 정량적 중합효소 연쇄 반응(qPCR) 기술을 활용한 분자진단기기 '스마트칩(SmartChip)'을 도입했습니다. 이 장비는 우표 크기의 플레이트에 5,000개 이상의 시료를 수용할 수 있으며, 자동 처리 기능을 갖춘 384 시료 시스템과 결합하여 처리 능력을 더욱 향상시킬 수 있습니다. SmartChip은 미세유체 기술을 채택하여 표준 96웰 장비의 100분의 1의 시료량으로 대상 병원체를 효율적으로 식별할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Veterinary molecular diagnostics involves the use of molecular biology techniques to identify and diagnose animal diseases at the genetic or molecular level. These diagnostics detect specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that signal disease, assisting veterinarians in making precise diagnoses and treatment plans.
The main products in veterinary molecular diagnostics include kits, reagents, and instruments. Kits and reagents are crucial for conducting various diagnostic tests on animal samples in laboratories and industrial settings, providing accurate and reliable results necessary for effective treatment and management of diseases. These diagnostics are applicable to both companion animals and livestock, addressing conditions such as infectious and genetic diseases. The primary users of these products are diagnostic laboratories, veterinary clinics, veterinary hospitals, and similar facilities.
Tariffs have impacted the veterinary molecular diagnostics market by increasing the cost of imported kits, reagents, and advanced instruments such as PCR machines and DNA sequencers, affecting pricing and accessibility for diagnostic laboratories and veterinary clinics. Segments like kits and reagents and instruments are most affected, particularly in regions such as North America and Europe reliant on imports. However, tariffs have also stimulated local manufacturing, encouraged development of cost-effective diagnostic solutions, and fostered regional innovation in molecular veterinary diagnostics.
The veterinary molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides veterinary molecular diagnostics market statistics, including veterinary molecular diagnostics industry global market size, regional shares, competitors with a veterinary molecular diagnostics market share, detailed veterinary molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary molecular diagnostics industry. This veterinary molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary molecular diagnostics market size has grown strongly in recent years. It will grow from $0.7 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing prevalence of infectious and genetic animal diseases, technological advancements in molecular biology, growth of companion and livestock animal populations, rising veterinary awareness and training, adoption of conventional molecular diagnostic kits.
The veterinary molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rising demand for rapid and accurate molecular diagnostics, adoption of ngs and high-throughput platforms, expansion of veterinary genomics services, integration of ai-driven diagnostic analysis, growing emphasis on preventive veterinary care through molecular testing. Major trends in the forecast period include expansion of pcr and rt-pcr-based diagnostics, growing adoption of next-generation sequencing (ngs) in veterinary medicine, development of multiplex diagnostic kits for infectious diseases, integration of molecular diagnostics in routine veterinary care, automation and high-throughput molecular testing solutions.
The high prevalence of zoonotic diseases is expected to drive the growth of the veterinary molecular diagnostics market going forward. Zoonotic diseases are infectious conditions transmitted between animals and humans, caused by bacteria, viruses, parasites, or fungi. Common examples include rabies, Lyme disease, salmonellosis, toxoplasmosis, and more. The prevalence of these diseases is influenced by factors such as deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics enable early detection of zoonotic diseases in animals, preventing transmission to humans and improving disease management through rapid and accurate pathogen identification. For example, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, the number of reported human cases of key zoonotic diseases in 2024-such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases)-continued to rise, highlighting the ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is driving the veterinary molecular diagnostics market.
Leading players in the veterinary molecular diagnostics market are focusing on automation and scalability in diagnostic technologies, such as high-volume testing machines, to enhance diagnostic accuracy, increase testing efficiency, and enable faster disease detection in animals. High-volume testing machines are advanced diagnostic devices capable of processing large numbers of samples efficiently, supporting rapid and accurate analysis in laboratory or clinical settings, especially for large-scale testing. For instance, in June 2023, Iowa State University's Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a molecular diagnostic device utilizing quantitative polymerase chain reaction (qPCR) technology. This device can accommodate over 5,000 samples on a plate no larger than a postage stamp, and its capacity increases further when paired with a 384-sample system featuring automated handling. SmartChip employs microfluidic technology, using a sample volume 100 times smaller than standard 96-well machines, to identify targets of interest efficiently.
In April 2023, Mars Incorporated, a US-based diversified manufacturing and petcare company, acquired Heska Corporation for approximately $1.3 billion. Through this acquisition, Mars aimed to strengthen and expand its petcare science and diagnostics capabilities by broadening its veterinary diagnostic offerings and accelerating innovation in point-of-care solutions for the global pet healthcare market. Heska Corporation is a US-based healthcare technology company specializing in the development, manufacture, marketing, and support of advanced veterinary diagnostic and specialty products for veterinary practitioners worldwide.
Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMerieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.
North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary molecular diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance testing, genetic testing, toxicology, and biocompatibility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary molecular diagnostics market also includes sales of immunoassay kits, diagnostic software, and next-generation sequencing (NGS) systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veterinary molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary molecular diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Kits And Reagents; Instruments
2) By Animal Type: Companion Animals; Livestock Animals
3) By Application: Infectious Diseases; Genetic Diseases; Other Applications
4) By End-User: Diagnostic Laboratories; Veterinary Clinics; Veterinary Hospitals; Other End-Users
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Expansion Of Pcr And Rt-Pcr-Based Diagnostics
4.2.2 Growing Adoption Of Next-Generation Sequencing (Ngs) In Veterinary Medicine
4.2.3 Development Of Multiplex Diagnostic Kits For Infectious Diseases
4.2.4 Integration Of Molecular Diagnostics In Routine Veterinary Care
4.2.5 Automation And High-Throughput Molecular Testing Solutions
5. Veterinary Molecular Diagnostics Market Analysis Of End Use Industries
5.1 Diagnostic Laboratories
5.2 Veterinary Clinics
5.3 Veterinary Hospitals
5.4 Research Institutes
5.5 Academic And Veterinary Training Centers
6. Veterinary Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Veterinary Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Veterinary Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Veterinary Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Veterinary Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Veterinary Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Veterinary Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.1. Global Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Kits And Reagents, Instruments
9.2. Global Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Companion Animals, Livestock Animals
9.3. Global Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Infectious Diseases, Genetic Diseases, Other Applications
9.4. Global Veterinary Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users
9.5. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems
10. Veterinary Molecular Diagnostics Market Regional And Country Analysis
10.1. Global Veterinary Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Veterinary Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Veterinary Molecular Diagnostics Market
12.1. China Veterinary Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Veterinary Molecular Diagnostics Market
13.1. India Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Veterinary Molecular Diagnostics Market
14.1. Japan Veterinary Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Veterinary Molecular Diagnostics Market
15.1. Australia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Veterinary Molecular Diagnostics Market
16.1. Indonesia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Veterinary Molecular Diagnostics Market
17.1. South Korea Veterinary Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Veterinary Molecular Diagnostics Market
19.1. South East Asia Veterinary Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Veterinary Molecular Diagnostics Market
20.1. Western Europe Veterinary Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Veterinary Molecular Diagnostics Market
21.1. UK Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Veterinary Molecular Diagnostics Market
23.1. France Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Veterinary Molecular Diagnostics Market
24.1. Italy Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Veterinary Molecular Diagnostics Market
25.1. Spain Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Veterinary Molecular Diagnostics Market
26.1. Eastern Europe Veterinary Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Veterinary Molecular Diagnostics Market
27.1. Russia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Veterinary Molecular Diagnostics Market
28.1. North America Veterinary Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Veterinary Molecular Diagnostics Market
29.1. USA Veterinary Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Veterinary Molecular Diagnostics Market
31.1. South America Veterinary Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Veterinary Molecular Diagnostics Market
32.1. Brazil Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Veterinary Molecular Diagnostics Market
33.1. Middle East Veterinary Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Veterinary Molecular Diagnostics Market
34.1. Africa Veterinary Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Veterinary Molecular Diagnostics Market Regulatory and Investment Landscape
36. Veterinary Molecular Diagnostics Market Competitive Landscape And Company Profiles
